4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-080869
Chief Scientific Officer sold 52,448 shares at an average $20.02 ($1,049,960)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Reich Kristian · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-21 | Sale : show line 1 in the form 10b5-1 | −50,000 | $20.02 | $1,001,000 | 2,714,746 | I |
| 2026-07-22 | Sale : show line 2 in the form 10b5-1 | −2,448 | $20.00 | $48,960 | 2,712,298 | I |
| Open-market sales · 52,448 sh · avg $20.02 · $1,049,960 | ||||||
Loading xslF345X06/ownership.xml…